Cell surface nucleolin is crucial in the activation of the CXCL12/CXCR4 signaling pathway

Tumor Biology

Volumn 35, Issue 1, 2014, Pages 333-338

  Yang, Xiangshan ^a   Xu, Zhongfa ^a   Li, Daotang ^a   Cheng, Shaomei ^a   Fan, Kaixi ^a   Li, Chengjun ^a   Li, Aiping ^a   Zhang, Jing ^a   Feng, Man ^a  

^a SHANDONG PROVINCIAL HOSPITAL AFFILIATED TO SHANDONG FIRST MEDICAL UNIVERSITY   (China)

Author keywords

Cell surface nucleolin; CXCR4; Interaction; Papillary thyroid carcinoma

Indexed keywords

CHEMOKINE RECEPTOR CXCR4; MITOGEN ACTIVATED PROTEIN KINASE; NUCLEOLIN; SMALL INTERFERING RNA;

ARTICLE; CANCER THERAPY; CELL MIGRATION; CELL PROLIFERATION; COLONY FORMATION; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; PRIORITY JOURNAL; THYROID CARCINOMA; THYROID PAPILLARY CARCINOMA; WESTERN BLOTTING;

CARCINOMA; CELL LINE, TUMOR; CELL MEMBRANE; CELL MOVEMENT; CELL PROLIFERATION; CHEMOKINE CXCL12; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GENE EXPRESSION; HUMANS; PHOSPHOPROTEINS; PHOSPHORYLATION; PROTEIN BINDING; RECEPTORS, CXCR4; RNA-BINDING PROTEINS; SIGNAL TRANSDUCTION; THYROID NEOPLASMS;

EID: 84894495964     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-013-1044-0     Document Type: Article

References (26)

1. Nikiforov YE. Thyroid carcinoma: molecular pathways and therapeutic targets. Mod Pathol. 2008;21:S37-43.
2. Oberlin E, Amara A, Bachelerie F, Bessia C, Virelizier JL, Arenzana- Seisdedos F, et al. The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1. Nature. 1996;385:833-5.
3. Balkwill F. Cancer and the chemokine network. Nat Rev Cancer. 2004;4:540-50.
4. Ratajczak MZ, Zuba-Surma E, Kucia M, Reca R, Wojakowski W, Ratajczak J. The pleiotropic effects of the SDF-1-CXCR4 axis in organogenesis, regeneration and tumorigenesis. Leukemia. 2006;20: 1915-24.
5. Saur D, Seidler B, Schneider G, Algül H, Beck R, Senekowitsch- Schmidtke R, et al. CXCR4 expression increases liver and lung metastasis in a mouse model of pancreatic cancer. Gastroenterology. 2005;129:1237-50.
6. Yasuoka H, Kodama R, Hirokawa M, Takamura Y, Miyauchi A, Sanke T, et al. CXCR4 expression in papillary thyroid carcinoma: induction by nitric oxide and correlation with lymph nodemetastasis. BMC Cancer. 2008;30(8):274.
7. González HE, Leiva A, Tobar H, Böhmwald K, Tapia G, Torres J, et al. Altered chemokine receptor expression in papillary thyroid cancer. Thyroid. 2009;19:957-65.
8. Hamlyn E, Hickling S, Porter K, Frater J, Phillips R, Robinson M, et al. Increased levels of CD4 T-cell activation in individuals with CXCR4 using viruses in primary HIV-1 infection. AIDS. 2012;26:887-90.
9. Rubin JB, Kung AL, Klein RS, Chan JA, Sun Y, Schmidt K, et al. A small-molecule antagonist of CXCR4 inhibits intracranial growth of primary brain tumors. Proc Natl Acad Sci USA. 2003;100:13513-8.
10. Orrick LR, OlsonMO, Busch H. Comparison of nucleolar proteins of normal rat liver and Novikoff hepatoma ascites cells by twodimensional polyacrylamide gel electrophoresis. Proc Natl Acad Sci USA. 1973;70:1316-20.
11. Zhuo W, Luo C, Wang X, Song X, Fu Y, Luo Y. Endostatin inhibits tumour lymphangiogenesis and lymphatic metastasis via cell surface nucleolin on lymphangiogenic endothelial cells. J Pathol. 2010;222: 249-60.
12. Harms G, Kraft R, Grelle G, Volz B, Dernedde J, Tauber R. Identification of nucleolin as a new L-selectin ligand. Biochem J. 2001;360:531-8.
13. Alete DE, Weeks ME, Hovanession AG, Hawadle M, Stoker. AW Cell surface nucleolin on developing muscle is a potential ligand for the axonal receptor protein tyrosine phosphatase-sigma. FEBS J. 2006;273:4668-81.
14. Nisole S, Krust B, Callebaut C, Guichard G, Muller S, Briand JP, et al. The anti-HIV pseudopeptide HB-19 forms a complex with the cell-surface-expressed nucleolin independent of heparan sulfate proteoglycans. J Biol Chem. 1999;274:27875-84.
15. Rossi D, Zlotnik A. The biology of chemokines and their receptors. Annu Rev Immunol. 2000;18:217-42.
16. Zlotnik A, Yoshie O. Chemokines: a new classification system and their role in immunity. Immunity. 2000;12:121-7.
17. Balkwill F. Chemokine biology in cancer. Semin Immunol. 2003; 15:49-55.
18. Liu J, Liao S, Huang Y, Samuel R, Shi T, Naxerova K, et al. PDGF-D improves drug delivery and efficacy via vascular normalization, but promotes lymphatic metastasis by activating CXCR4 in breast cancer. Clin Cancer Res. 2011;17:3638-48.
19. Zhiqiang X, Joshi N, Agarwal A. Knocking down nucleolin expression in gliomas inhibits tumor growth and induces cell cycle arrest. J Neurooncol. 2012;108:59-67.
20. Otake Y, Soundararajan S, Sengupta TK, Kio EA, Smith JC, Pineda- RomanM, et al. Overexpression of nucleolin jn chronic lymphocytic leukemia cells induces stabilization of bcl2 mRNA. Blood. 2007;109:3069-75.
21. Hovanessian A. Midkine, a cytokine that inhibits HIV infection by binding to the cell surface expressed nucleolin. Cell Res. 2006; 16:174-81.
22. Schlessinger J. Cell signaling by receptor tyrosine kinases. Cell. 2000;103:211-25.
23. Esparza GA, Teghanemt A, Zhang D, Gioannini TL, Weiss JP. Endotoxin{middle dot}albumin complexes transfer endotoxinmonomers to MD-2 resulting in activation of TLR4. Innate Immun. 2012; 18:478-91.
24. Venkatesan S, Rose JJ, Lodge R, Murphy PM, Foley JF. Distinct mechanisms of agonist-induced endocytosis for human chemokine receptors CCR5 and CXCR4. Mol Biol Cell. 2003;14:3305-24.
25. Marchese A, Benovic JL. Agonist-promoted ubiquitination of the G protein-coupled receptor CXCR4 mediates lysosomal sorting. J Biol Chem. 2001;276:45509-12.
26. Mueller A, Kelly E, Strange PG. Pathways for internalization and recycling of the chemokine receptor CCR5. Blood. 2002;99:785-91.